Sigachi Industries Limited (SIGACHI) AI Stock Analysis

• Market Cap: ₹7.11B
• Dividend Yield: 0.29%
• Average Volume (3M): 4.02M
• Price to Earnings (P/E): 1509.1
• Beta (1Y): 1.70
• Revenue Growth: 16.22%
• EPS Growth: -165.88%
• Country: IN
• Employees: 991
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): <0.01
• Shares Outstanding: 382,117,000
• 10 Day Avg. Volume: 214,185
• 30 Day Avg. Volume: 4,018,216
• PEG Ratio: 1.27
• Price to Book (P/B): 2.02
• Price to Sales (P/S): 2.49
• P/FCF Ratio: -50.04
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 57 Neutral
• Price Target: ₹23.50 ▼(-25.04% Downside)
• Action: Downgraded Date: 01/28/26
• Date: Action: Downgraded 01/28/26

Overall score is held back primarily by very weak technicals (sharp downtrend and severely bearish momentum readings). Financial performance remains a relative strength thanks to strong growth and profitability, but negative free cash flow is a meaningful risk. Valuation signals are mixed due to a negative P/E and a low dividend yield.

Positive Factors

Revenue & Margin Strength

Consistent revenue growth coupled with robust gross and improving net margins reflects durable demand for Sigachi's MCC products and disciplined cost management. Sustained margin performance supports reinvestment in capacity and quality controls, bolstering long-term profitability and resilience across cycles.

Balance Sheet Stability

A healthy equity base and manageable leverage provide financial flexibility to fund strategic capex, absorb shocks and support supply continuity to pharma customers. Strong ROE indicates effective use of capital, underpinning the company's ability to pursue growth while maintaining credit access over the medium term.

Product Specialization (MCC)

Deep specialization in microcrystalline cellulose creates high technical and regulatory barriers to entry, fostering sticky B2B relationships with pharmaceutical customers. Focused product expertise enables premium grading, repeat volumes and cross-sales into food and nutraceuticals, supporting steady structural demand.

Negative Factors

Negative Free Cash Flow

Persistent negative free cash flow driven by sustained capex reduces internal funding capacity and forces external financing. Over months this constrains strategic flexibility, raises refinancing and interest risks, and can limit the firm's ability to invest in capacity or weather demand shocks without dilutive or costly funding.

Earnings Volatility

A sharp decline in EPS signals meaningful earnings volatility or one-off pressures that undermine predictable profitability. Persistent swings in earnings complicate capital planning and reduce confidence in sustained cash generation, making it harder to finance growth or return capital without external support.

Elevated Leverage Risk

Although leverage is currently manageable, slightly elevated debt amplifies risk given negative FCF and ongoing capex needs. Over a multi-month horizon, this increases sensitivity to interest costs and limits borrowing headroom, potentially forcing deferred investment or higher-cost financing if cash flows don't improve.

Sigachi Industries Limited Business Overview & Revenue Model

Company Description

Sigachi Industries Limited manufactures and sells microcrystalline cellulose and cellulose powder in India. It serves pharmaceutical and nutraceutical, food and nutrition, cosmetic, and chemical industries. The company also exports its products. Sigachi Industries Limited was incorporated in 1989 and is based in Hyderabad, India.

How the Company Makes Money

Sigachi Industries generates revenue primarily through the sale of microcrystalline cellulose, which is utilized in a broad range of applications in the pharmaceutical, food, and cosmetic industries. The company's revenue model is based on direct sales to manufacturers and distributors, as well as exports to international markets. Key revenue streams include bulk sales to pharmaceutical companies for use in drug formulations, food manufacturers for use as a food additive, and cosmetics companies for various applications. Additionally, Sigachi may benefit from strategic partnerships with key players in these industries, enhancing its market reach and driving sales growth. The company's commitment to quality and innovation further positions it competitively within the specialty chemicals market, contributing to its earnings.

Sigachi Industries Limited Financial Statement Overview

Summary

Strong revenue growth and robust profitability margins support a solid financial profile (Income Statement score 85). Balance sheet is healthy with good equity backing and manageable—though slightly elevated—leverage (Balance Sheet score 78). Cash flow is the key constraint: free cash flow remains negative due to high capex and increased reliance on external funding (Cash Flow score 72).

Income Statement

Sigachi Industries Limited has demonstrated strong revenue growth with a notable increase from 2024 to 2025. The gross profit margin remains robust, indicating efficient cost management. Consistently improving net profit margin and solid EBIT and EBITDA margins reflect sound profitability. However, the pace of margin improvements has moderated, which could be a potential area to monitor.

Balance Sheet

The company's balance sheet shows a healthy equity position with a solid equity ratio, indicating financial stability. The debt-to-equity ratio is manageable, though slightly elevated, suggesting potential leverage risks. Return on equity is commendable, showcasing effective use of equity capital to generate profits. Overall, the balance sheet is strong, but vigilance on leverage is advised.

Cash Flow

Operating cash flow has improved, but free cash flow remains negative due to high capital expenditures. While the operating cash flow to net income ratio is healthy, the free cash flow to net income ratio indicates a need for better cash management. The growth in financing cash flow suggests reliance on external funding, which could impact future flexibility.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	5.06B	4.88B	3.99B	3.02B	2.50B	1.93B
Gross Profit	2.16B	1.77B	1.73B	1.64B	1.12B	738.38M
EBITDA	-123.49M	1.21B	858.35M	653.97M	556.74M	420.44M
Net Income	-550.46M	695.63M	571.80M	435.36M	400.37M	302.60M
Balance Sheet
Total Assets	8.51B	8.46B	6.94B	3.74B	2.87B	1.33B
Cash, Cash Equivalents and Short-Term Investments	817.74M	720.20M	570.57M	327.50M	693.83M	180.16M
Total Debt	1.67B	1.45B	1.51B	684.78M	349.03M	209.27M
Total Liabilities	3.32B	2.33B	2.53B	1.05B	590.20M	392.08M
Stockholders Equity	5.08B	6.01B	4.30B	2.68B	2.28B	941.99M
Cash Flow
Free Cash Flow	-727.44M	-242.98M	-722.97M	-716.99M	-184.80M	202.67M
Operating Cash Flow	-727.44M	190.32M	128.92M	290.17M	58.50M	295.51M
Investing Cash Flow	640.50M	-975.84M	-1.61B	-918.52M	-628.58M	-114.32M
Financing Cash Flow	184.48M	935.15M	1.72B	262.08M	1.08B	-106.92M

Sigachi Industries Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 31.35
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SIGACHI, the sentiment is Negative. The current price of 31.35 is above the 20-day moving average (MA) of 20.35, above the 50-day MA of 23.37, and below the 200-day MA of 35.56, indicating a bearish trend. The MACD of -1.40 indicates Negative momentum. The RSI at 29.91 is Positive, neither overbought nor oversold. The STOCH value of 30.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SIGACHI.

Sigachi Industries Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GANESHBE	63 Neutral	₹5.60B	9.06	―	―	-12.30%	-26.40%
SADHNANIQ	63 Neutral	₹5.28B	-2.39	―	1.25%	-37.44%	-950.73%
KHAICHEM	62 Neutral	₹4.84B	9.32	―	―	67.43%	―
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SIGACHI	57 Neutral	₹7.11B	1,509.07	―	0.29%	16.22%	-165.88%
KRITI	44 Neutral	₹4.21B	-229.02	―	0.22%	-19.06%	-175.93%

Sigachi Industries Limited Corporate Events

Sigachi CEO Remanded in Probe Into Hyderabad Plant Fire; Deputy Group CEO Steps In

Sigachi Industries Limited has disclosed that its Managing Director and CEO, Amit Raj Sinha, was remanded on 27 December 2025 in connection with an ongoing investigation into a fire incident that occurred on 30 June 2025 at the company’s Hyderabad unit in Pashamylaram. The company stated that it has implemented necessary measures to maintain continuity of operations and day-to-day activities, with Deputy Group CEO Lijo Stephen Chacko temporarily overseeing the company’s operations, signaling an effort to stabilize management and reassure stakeholders amid the investigation.